Live Breaking News & Updates on Aurinia Pharmaceuticals Trading Down

Stay updated with breaking news from Aurinia pharmaceuticals trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 9.9% in April

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 9.9% in April
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Institutional Trading Of Aurinia Pharmaceuticals , Otsuka Pharmaceutical Co Ltd , Sunbelt Securities Inc , Goldman Sachs Group Inc , Aurinia Pharmaceuticals , Aurinia Pharmaceuticals Inc , Campbell Co Investment Adviser , Armistice Capital , Aurinia Pharmaceuticals Trading Down , News Ratings For Aurinia Pharmaceuticals Daily , Jefferies Financial Group , Capital Partners , Royal Bank , Cantor Fitzgerald , Get Free Report , Pharmaceuticals Trading Down , Sachs Group , Sunbelt Securities , Financial Group , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily ,

Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 52-Week Low Following Weak Earnings

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) shares reached a new 52-week low during trading on Thursday after the company announced weaker than expected quarterly earnings. The company traded as low as $5.50 and last traded at $5.91, with a volume of 6703556 shares traded. The stock had previously closed at $7.97. The […] ....

United States , Otsuka Pharmaceutical Co Ltd , Sg Americas Securities , Aurinia Pharmaceuticals Inc , Jefferies Financial Group , Swiss National Bank , Aurinia Pharmaceuticals Trading Down , Institutional Investors Weigh In On Aurinia Pharmaceuticals , Aurinia Pharmaceuticals , News Ratings For Aurinia Pharmaceuticals Daily , Royal Bank , Allspring Global Investments Holdings , Mirae Asset Global Investments Co , Hennion Walsh Asset Management Inc , Get Free Report , Financial Group , Global Investments Holdings , National Bank , Asset Global Investments , Walsh Asset Management , Pharmaceuticals Trading Down , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph ,

Aurinia Pharmaceuticals' (AUPH) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright restated their buy rating on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) in a research note released on Friday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the biotechnology company’s stock. Separately, StockNews.com assumed coverage on shares of Aurinia Pharmaceuticals in a report on Thursday, August 17th. […] ....

United States , Aurinia Pharmaceuticals , Otsuka Pharmaceutical Co Ltd , Aurinia Pharmaceuticals Inc , Renaissance Technologies , Armistice Capital , Aurinia Pharmaceuticals Trading Down , News Ratings For Aurinia Pharmaceuticals Daily , Institutional Trading Of Aurinia Pharmaceuticals , Bellevue Group , Free Report , Moderate Buy , Pharmaceuticals Trading Down , Get Free Report , Street Corp , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph , Reiterated Rating , Hc Wainwright ,

Aurinia Pharmaceuticals (TSE:AUP) Shares Down 3.5%

Aurinia Pharmaceuticals Inc. (TSE:AUP – Get Free Report) (NASDAQ:AUPH) shares fell 3.5% during mid-day trading on Monday . The stock traded as low as C$16.41 and last traded at C$16.76. 4,611,683 shares traded hands during trading, an increase of 1,906% from the average session volume of 229,895 shares. The stock had previously closed at C$17.37. […] ....

News Ratings For Aurinia Pharmaceuticals Daily , Aurinia Pharmaceuticals , Otsuka Pharmaceutical Co Ltd , Aurinia Pharmaceuticals Trading Down , Aurinia Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Trading Down , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Tse Aup , Computer And Technology ,

Aurinia Pharmaceuticals (NASDAQ:AUPH) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) in a report released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Several other equities analysts also recently commented on the company. Royal Bank of Canada upped their price objective on Aurinia Pharmaceuticals from $11.00 to […] ....

United States , Nova Scotia , Davidrw Jayne , Insider Transactions At Aurinia Pharmaceuticals , Armistice Capital , Aurinia Pharmaceuticals Trading Down , News Ratings For Aurinia Pharmaceuticals Daily , Aurinia Pharmaceuticals Company Profile , Otsuka Pharmaceutical Co Ltd , Blackrock Inc , Royal Bank , Bellevue Group , Aurinia Pharmaceuticals , Aurinia Pharmaceuticals Inc , Free Report , Moderate Buy , Pharmaceuticals Trading Down , Get Free Report , Street Corp , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph , Initiated Coverage , Stocknews Com ,